Gastrointestinal fluid retention

"Gastrointestinal fluid retention" is not a specific molecular target, receptor, enzyme, or protein. Instead, it describes a physiological or pathological state where excess fluid accumulates within the gastrointestinal tract or related compartments. This can occur as part of systemic conditions such as edema, ascites due to liver cirrhosis[5][6], heart failure[6], kidney disease[6], or as a result of altered absorption and secretion processes in the gut. Fluid balance in the GI tract is regulated by complex interactions involving epithelial transporters and channels for sodium and water absorption/secretion—primarily through enterocytes lining the intestinal epithelium[2]. However, there is no single molecule called "gastrointestinal fluid retention." Rather, this term refers to an outcome resulting from dysregulation of multiple pathways including hormonal systems like the renin–angiotensin–aldosterone system and vasopressin signaling[5]. Therapeutic interventions for GI-related fluid overload focus on treating underlying causes (e.g., liver disease) with drugs such as diuretics or vasopressin antagonists to promote excretion of retained fluids. Monitoring may involve tracking ascitic volume rather than any specific biomarker for a molecular target. In summary, "gastrointestinal fluid retention" should not be considered a canonical drug target but rather a clinical phenomenon arising from various pathophysiological mechanisms affecting body water distribution and homeostasis[5][6].

Other names

Gastrointestinal fluid retentionGI fluid retentionWater retention in the gastrointestinal tract

Promote renal excretion of sodium and water (diuretics); Block vasopressin-mediated water reabsorption (vasopressin antagonists)